CS275793B6 - Production method of the antivirus and antitumour agent - Google Patents

Production method of the antivirus and antitumour agent Download PDF

Info

Publication number
CS275793B6
CS275793B6 CS865798A CS579886A CS275793B6 CS 275793 B6 CS275793 B6 CS 275793B6 CS 865798 A CS865798 A CS 865798A CS 579886 A CS579886 A CS 579886A CS 275793 B6 CS275793 B6 CS 275793B6
Authority
CS
Czechoslovakia
Prior art keywords
sodium
potassium
acid
xanthate
cells
Prior art date
Application number
CS865798A
Other languages
Czech (cs)
English (en)
Other versions
CS8605798A2 (en
Inventor
Gerhard Sauer
Eberhard Amtmann
Klaus W Hummel
Original Assignee
Merz & Co Gmbh & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merz & Co Gmbh & Co filed Critical Merz & Co Gmbh & Co
Publication of CS8605798A2 publication Critical patent/CS8605798A2/cs
Publication of CS275793B6 publication Critical patent/CS275793B6/cs

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/265—Esters, e.g. nitroglycerine, selenocyanates of carbonic, thiocarbonic, or thiocarboxylic acids, e.g. thioacetic acid, xanthogenic acid, trithiocarbonic acid

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
CS865798A 1985-08-02 1986-08-01 Production method of the antivirus and antitumour agent CS275793B6 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3527871 1985-08-02

Publications (2)

Publication Number Publication Date
CS8605798A2 CS8605798A2 (en) 1990-10-12
CS275793B6 true CS275793B6 (en) 1992-03-18

Family

ID=6277597

Family Applications (1)

Application Number Title Priority Date Filing Date
CS865798A CS275793B6 (en) 1985-08-02 1986-08-01 Production method of the antivirus and antitumour agent

Country Status (7)

Country Link
KR (1) KR860008777A (es)
AT (1) AT388499B (es)
CS (1) CS275793B6 (es)
DD (1) DD286971A5 (es)
ES (1) ES2000384A6 (es)
HU (1) HU197212B (es)
PT (1) PT83127B (es)

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1140M (fr) * 1961-05-16 1962-02-19 Johnson & Johnson Composition chimiothérapique a efficacité accrue.
US4164573A (en) * 1975-06-13 1979-08-14 Galinsky Alvin M Composition and method for making a suppository for introducing a hypoglycemic agent into a mammal
IT1202370B (it) * 1976-07-12 1989-02-09 Hoffmann La Roche Soluzioni inietabili in cui l'atti vita' emolitica degli agenti di formazione di micelle naturali e' evitata mediante l'aggiunta di lipoidi e relativi prodotti
JPS5940137B2 (ja) * 1976-10-14 1984-09-28 武田薬品工業株式会社 経口投与用医薬組成物
JPS54122719A (en) * 1978-03-16 1979-09-22 Sankyo Co Ltd Carcinostatic agent for oral administration
JPS56100711A (en) * 1980-01-16 1981-08-12 Teijin Ltd Pharmaceutical for remedy of uterine cancer
CA1174978A (en) * 1980-11-26 1984-09-25 Arthur Scherm Xanthates
AR230264A1 (es) * 1980-11-26 1984-03-01 Merz & Co Gmbh & Co Procedimiento para la obtencion de compuestos de xantato
US4578391A (en) * 1982-01-20 1986-03-25 Yamanouchi Pharmaceutical Co., Ltd. Oily compositions of antitumor drugs
JPS58124714A (ja) * 1982-01-20 1983-07-25 Yamanouchi Pharmaceut Co Ltd 抗腫瘍物質の油性組成物
DE3218121A1 (de) * 1982-05-14 1983-11-17 Leskovar, Peter, Dr.-Ing., 8000 München Arzneimittel zur tumorbehandlung

Also Published As

Publication number Publication date
AT388499B (de) 1989-06-26
HU197212B (en) 1989-03-28
KR860008777A (ko) 1986-12-18
CS8605798A2 (en) 1990-10-12
ES2000384A6 (es) 1991-03-16
HUT42949A (en) 1987-09-28
DD286971A5 (de) 1991-02-14
ATA208786A (de) 1988-12-15
PT83127B (pt) 1989-03-30
PT83127A (en) 1986-09-01

Similar Documents

Publication Publication Date Title
US7427606B2 (en) Method to reduce inflammatory response in transplanted tissue
JP3963976B2 (ja) クラミジア感染症治療剤
PT1385498E (pt) Ácidos gordos como factores de sobrevivência e activação de neutrófilos
HU203201B (en) Process for producing antitumoural pharmaceutical composition having synergetic effect
US4851435A (en) Antiviral and antitumor xanthate pharmaceutical compositions
SK138597A3 (en) A pharmaceutical composition containing n-chlorophenylcarbamates, n-chlorophenylthiocarbamates and n-phosphonoglycine derivatives for inhibiting the growth of cancers and viruses in mammals
JP3237836B2 (ja) 抗ウイルス医薬組成物
JPS62195337A (ja) 抗ウイルス性組成物
WO2016163082A1 (ja) Ａｌａ類を含むウイルス感染症予防／治療剤
HUT65634A (en) Process for producing pharmaceutical preparations containing quinones against cancer or aids
KR20000036210A (ko) 장쇄 알코올, 알칸, 지방산 및 아미드로 바이러스를 억제하는 방법
KR960000432B1 (ko) 제약학적 생성물
JPH0232093A (ja) 抗レトロウィルスジフルオロ化ヌクレオシド類
JPH08503699A (ja) 全身性炎症と炎症性肝炎の治療のためのピリミジンヌクレオチド前駆体
CS275793B6 (en) Production method of the antivirus and antitumour agent
Chaube et al. Protective effect of deoxycytidylic acid (CdMP) on hydroxyurea‐induced malformations in rats
JPH05507719A (ja) 薬学的治療
CN1098687C (zh) 氨基嘌呤抗病毒剂在治疗和预防潜伏性疱疹病毒感染中的用途
VENGRIS et al. Polymeric drugs: direct compared with indirect inhibition of leukemia virus replication in mice
KR970003049B1 (ko) 혈소판감소증 예방 및 치료제
JPH01313433A (ja) 抗ｈｉｖ剤
WO2023177995A2 (en) Cdp-choline a host-directed therapeutic for disease caused by sars cov-2 infection
EP0624368A2 (en) Use of a composition for stimulating the synthesis of glutathione in the manufacture of a medicament for the treatment of acquired immune deficiency syndrome
KR20010022033A (ko) 가축의 유선염 치료방법
JP2579486B2 (ja) 中枢神経抑制剤